A detailed history of California State Teachers Retirement System transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 173,145 shares of REGN stock, worth $126 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
173,145
Previous 173,727 0.34%
Holding current value
$126 Million
Previous $183 Million 0.32%
% of portfolio
0.22%
Previous 0.23%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $596,020 - $699,424
-582 Reduced 0.34%
173,145 $182 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $598,809 - $726,266
678 Added 0.39%
173,727 $183 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $1.49 Million - $1.64 Million
1,648 Added 0.96%
173,049 $167 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $512,393 - $582,803
661 Added 0.39%
171,401 $151 Million
Q3 2023

Nov 14, 2023

SELL
$692.45 - $844.37 $4.03 Million - $4.91 Million
-5,820 Reduced 3.3%
170,740 $141 Million
Q2 2023

Aug 21, 2023

SELL
$700.03 - $830.35 $2.21 Million - $2.62 Million
-3,159 Reduced 1.76%
176,560 $127 Million
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $1.25 Million - $1.51 Million
-1,830 Reduced 1.01%
179,719 $148 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $1.19 Million - $1.29 Million
1,679 Added 0.93%
181,549 $131 Million
Q3 2022

Nov 18, 2022

SELL
$573.97 - $724.32 $143,492 - $181,080
-250 Reduced 0.14%
179,870 $124 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $1.57 Million - $2.12 Million
2,863 Added 1.62%
180,120 $106 Million
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $5.08 Million - $5.96 Million
-8,530 Reduced 4.59%
177,257 $124 Million
Q4 2021

Feb 15, 2022

BUY
$543.48 - $670.97 $4.64 Million - $5.73 Million
8,546 Added 4.82%
185,787 $117 Million
Q3 2021

Nov 15, 2021

BUY
$574.03 - $680.96 $559,679 - $663,936
975 Added 0.55%
177,241 $107 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $4.65 Million - $5.49 Million
-9,837 Reduced 5.29%
176,266 $98.5 Million
Q1 2021

May 18, 2021

BUY
$446.73 - $548.2 $487,382 - $598,086
1,091 Added 0.59%
186,103 $88.1 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $2.12 Million - $2.69 Million
4,431 Added 2.45%
185,012 $89.4 Million
Q3 2020

Nov 17, 2020

BUY
$544.75 - $658.21 $2.95 Million - $3.56 Million
5,411 Added 3.09%
180,581 $101 Million
Q2 2020

Aug 17, 2020

BUY
$493.32 - $643.92 $14.5 Million - $19 Million
29,452 Added 20.21%
175,170 $109 Million
Q1 2020

May 13, 2020

SELL
$336.18 - $494.43 $171,115 - $251,664
-509 Reduced 0.35%
145,718 $71.2 Million
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $2.9 Million - $3.98 Million
10,572 Added 7.79%
146,227 $54.9 Million
Q3 2019

Nov 15, 2019

BUY
$273.46 - $318.39 $266,896 - $310,748
976 Added 0.72%
135,655 $37.6 Million
Q2 2019

Aug 14, 2019

BUY
$299.6 - $414.82 $674,399 - $933,759
2,251 Added 1.7%
134,679 $42.2 Million
Q1 2019

May 09, 2019

BUY
$372.08 - $439.57 $865,830 - $1.02 Million
2,327 Added 1.79%
132,428 $54.4 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $888,915 - $1.07 Million
2,647 Added 2.08%
130,101 $48.6 Million
Q3 2018

Nov 14, 2018

BUY
$351.14 - $408.51 $2,106 - $2,451
6 Added 0.0%
127,454 $51.5 Million
Q2 2018

Aug 14, 2018

BUY
$284.6 - $344.99 $383,071 - $464,356
1,346 Added 1.07%
127,448 $44 Million
Q1 2018

May 15, 2018

SELL
$315.82 - $393.78 $1.36 Million - $1.69 Million
-4,303 Reduced 3.3%
126,102 $43.4 Million
Q4 2017

Feb 14, 2018

SELL
$358.63 - $469.95 $275,427 - $360,921
-768 Reduced 0.59%
130,405 $49 Million
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $56.6 Million - $66.1 Million
131,173
131,173 $58.7 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $77.7B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.